164 related articles for article (PubMed ID: 18363997)
1. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.
Xiang R; Luo Y; Niethammer AG; Reisfeld RA
Immunol Rev; 2008 Apr; 222():117-28. PubMed ID: 18363997
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Immunol Rev; 2004 Jun; 199():181-90. PubMed ID: 15233734
[TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication.
Xiang R; Mizutani N; Luo Y; Chiodoni C; Zhou H; Mizutani M; Ba Y; Becker JC; Reisfeld RA
Cancer Res; 2005 Jan; 65(2):553-61. PubMed ID: 15695399
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines designed to inhibit tumor growth by suppression of angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Int Arch Allergy Immunol; 2004 Mar; 133(3):295-304. PubMed ID: 14988601
[TBL] [Abstract][Full Text] [Related]
5. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine.
Luo Y; Zhou H; Mizutani M; Mizutani N; Reisfeld RA; Xiang R
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8850-5. PubMed ID: 12857959
[TBL] [Abstract][Full Text] [Related]
7. FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice.
Luo Y; Markowitz D; Xiang R; Zhou H; Reisfeld RA
Vaccine; 2007 Feb; 25(8):1409-15. PubMed ID: 17113202
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccines suppress angiogenesis and protect against growth of breast cancer metastases.
Mizutani N; Luo Y; Mizutani M; Reisfeld RA; Xiang R
Breast Dis; 2004; 20():81-91. PubMed ID: 15687710
[TBL] [Abstract][Full Text] [Related]
9. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.
Niethammer AG; Xiang R; Becker JC; Wodrich H; Pertl U; Karsten G; Eliceiri BP; Reisfeld RA
Nat Med; 2002 Dec; 8(12):1369-75. PubMed ID: 12415261
[TBL] [Abstract][Full Text] [Related]
10. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
[TBL] [Abstract][Full Text] [Related]
13. Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis.
Zuo SG; Chen Y; Wu ZP; Liu X; Liu C; Zhou YC; Wu CL; Jin CG; Gu YL; Li J; Chen XQ; Li Y; Wei HP; Li LH; Wang XC
Biol Pharm Bull; 2010; 33(2):174-82. PubMed ID: 20118536
[TBL] [Abstract][Full Text] [Related]
14. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma.
Lladser A; Ljungberg K; Tufvesson H; Tazzari M; Roos AK; Quest AF; Kiessling R
Cancer Immunol Immunother; 2010 Jan; 59(1):81-92. PubMed ID: 19526360
[TBL] [Abstract][Full Text] [Related]
15. Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice.
Lladser A; Párraga M; Quevedo L; Carmen Molina M; Silva S; Ferreira A; Billetta R; G Quest AF
Immunobiology; 2006; 211(1-2):11-27. PubMed ID: 16446167
[TBL] [Abstract][Full Text] [Related]
16. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
Zhou H; Luo Y; Lo JF; Kaplan CD; Mizutani M; Mizutani N; Lee JD; Primus FJ; Becker JC; Xiang R; Reisfeld RA
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10846-51. PubMed ID: 16040807
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor efficacy of combined DNA vaccines targeting tumor cells and angiogenesis.
Yin X; Wang W; Zhu X; Wang Y; Wu S; Wang Z; Wang L; Du Z; Gao J; Yu J
Biochem Biophys Res Commun; 2015 Sep; 465(2):239-44. PubMed ID: 26253468
[TBL] [Abstract][Full Text] [Related]
18. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
19. Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.
Xiong G; Husseiny MI; Song L; Erdreich-Epstein A; Shackleford GM; Seeger RC; Jäckel D; Hensel M; Metelitsa LS
Int J Cancer; 2010 Jun; 126(11):2622-34. PubMed ID: 19824039
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.
Luo Y; Zhou H; Mizutani M; Mizutani N; Liu C; Xiang R; Reisfeld RA
Cancer Res; 2005 Apr; 65(8):3419-27. PubMed ID: 15833877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
